SCHEMBL17675144

SCHEMBL17675144

CC(C)COc1ccn(F)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35
GABRQ Q9UN88 1/20 0.35
BTK Q06187 1/20 0.33
ALDH1A1 P00352 3/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17662643 0.79 JMJD6 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25721921 0.79 GABRP (0.33) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20759271 0.78 DYRK1A (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19121008 0.76 ALDH1A1 (0.35) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17658873 0.75 GABRP (0.33) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17647128 0.73 MEN1 (0.39) BTKALDH1A1TSHRJMJD6HPGD
SCHEMBL19121337 0.73 TSHR (0.32) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL19122284 0.69 HTR3E (0.33) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL23182692 0.63 PTGER1 (0.35) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17662628 0.63 PLA2G7 (0.38) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed